<DOC>
	<DOCNO>NCT02255604</DOCNO>
	<brief_summary>The investigator want investigate whether specific immunotherapy deliver directly lymph node . The investigator think direct introduction allergen antigen present cell lymph node give strong immune response change number injection need allergen immunotherapy . The investigator measurement clinical effect variety paraclinical test see investigator find af biomarker successful specific immune therapy grass allergy .</brief_summary>
	<brief_title>Effect Intralymphatic Immunotherapy</brief_title>
	<detailed_description>Patients inject 3 4 dos alk 225 Phleum Pratense 1000 standard quantity units/ml lymph node groin . The investigator monitor clinical response use medication grass pollen season . SMS ( Symptom Medication Score ) use . The investigator count number immunoglobulin E grass produce plasma cell blood one week injection . The investigator also basophil activation test , nasal provocation test titrate skin prick test monitor effect . Adverse event record .</detailed_description>
	<criteria>Allergic rhinitis grass pollen , 3 mm reaction skin prick test grass , age 18 40 year . Uncontrolled asthma . Severe asthma post bronchodilator test force expiratory volume 1 second less 70 % expect . Severe co morbidity . Allergy Fenol Aluminium hydroxid . Any autoimmune disease . Treatment beta block medicine . Any heart diseases . Severe arterial hypertension . Kidney failure . Known malignancy . Known pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Allergen immunotherapy</keyword>
</DOC>